Status:

COMPLETED

Community Trial in the Cherokee Nation

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Opioid Abuse

Eligibility:

All Genders

15-17 years

Phase:

NA

Brief Summary

The target population is students attending high schools in small rural towns in the 14 counties that partially or fully fall within the Cherokee Nation reservation. Following recruitment of 20 school...

Detailed Description

The national public health opioid crisis has disproportionately burdened rural White populations, and disproportionately burdened American Indian populations. Therefore, the Cherokee Nation (CN) and E...

Eligibility Criteria

Inclusion

  • Tenth grade students enrolled in the participating high schools

Exclusion

  • unable to understand written or verbal English
  • Inclusion criteria for high schools:
  • Counties that partially or fully fall within the Cherokee Nation reservation
  • Town population of 3,000 or less
  • Class size between 30 to 100 students
  • Exclusion criteria for high schools:
  • Metropolitan and micropolitan cores (Rural-Urban Commuting Area codes of 1 and 4)
  • Existence of a community drug prevention coalition

Key Trial Info

Start Date :

September 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

919 Patients enrolled

Trial Details

Trial ID

NCT04839978

Start Date

September 29 2021

End Date

December 31 2024

Last Update

June 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cherokee Nation Reservation

Tahlequah, Oklahoma, United States, 74464